| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2022 | ECLIPSE BIOINNOVATIONS, INC | 5770 OBERLIN DR | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | Human Genome Research | 000 | 3 | 2/6/2024 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| 2023 | 2021 | ECLIPSE BIOINNOVATIONS, INC. | 5770 OBERLIN DR | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | Human Genome Research | 000 | 2 | 11/18/2022 | COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $861,551 ) |
| 2022 | 2022 | ECLIPSE BIOINNOVATIONS, INC. | 5770 OBERLIN DR | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | Human Genome Research | 001 | 3 | 9/20/2022 | NON-COMPETING CONTINUATION | $0 |
| 2022 | 2022 | ECLIPSE BIOINNOVATIONS, INC. | 5770 OBERLIN DR | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | Human Genome Research | 000 | 3 | 9/9/2022 | NON-COMPETING CONTINUATION | $861,551 |
|
| Issue Date FY: 2021 ( Subtotal = $1,137,682 ) |
| 2021 | 2021 | ECLIPSE BIOINNOVATIONS, INC. | 6195 CORNERSTONE CT E STE 105 | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | Human Genome Research | 000 | 2 | 9/22/2021 | COMPETING CONTINUATION | $1,137,682 |
|
|